Identification of sensitivity markers for BMS-536924, an inhibitor for insulin- like growth factor-1 receptor

被引：0
|
作者：
Huang, F.
Hurlburt, W.
Hafezi, R.
Han, X.
Chen, J.
Carboni, J.
Attar, R. M.
Helman, L.
Clark, E.
Dongre, A.
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
[2] NCI, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3506
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors
    Huang, Fei
    Greer, Ann
    Hurlburt, Warren
    Han, Xia
    Hafezi, Rameh
    Wittenberg, Gayle M.
    Reeves, Karen
    Chen, Jiwen
    Robinson, Douglas
    Li, Aixin
    Lee, Francis Y.
    Gottardis, Marco M.
    Clark, Edwin
    Helman, Lee
    Attar, Ricardo M.
    Dongre, Ashok
    Carboni, Joan M.
    CANCER RESEARCH, 2009, 69 (01) : 161 - 170
  • [2] The mechanisms of differential sensitivity to an insulin-like growth factor-1 receptor inhibitor (BMS-536924) and rationale for combining with EGFR/HER2 inhibitors
    Huang, F.
    Greer, A.
    Hurlburt, W.
    Han, X.
    Hafezi, R.
    Wittenberg, G. M.
    Reeves, K.
    Chen, J.
    Robinson, D.
    Li, A.
    Lee, F. Y.
    Gottardis, M. M.
    Clark, E.
    Helman, L.
    Attar, R. M.
    Dongre, A.
    Carboni, J. M.
    CANCER RESEARCH, 2009, 69 (05) : 2149 - 2149
  • [3] HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924
    Haluska, Paul
    Carboni, Joan M.
    TenEyck, Cynthia
    Attar, Ricardo M.
    Hou, Xiaonan
    Yu, Chunrong
    Sagar, Malvika
    Wong, Tai W.
    Gottardis, Marco M.
    Erlichman, Charles
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (09) : 2589 - 2598
  • [4] Expression of Insulin Receptor Isoform A and Insulin-like Growth Factor-1 Receptor in Human Acute Myelogenous Leukemia: Effect of the Dual-Receptor Inhibitor BMS-536924 In vitro
    Hendrickson, Andrea E. Wahner
    Haluska, Paul
    Schneider, Paula A.
    Loegering, David A.
    Peterson, Kevin L.
    Attar, Ricardo
    Smith, B. Douglas
    Erlichman, Charles
    Gottardis, Marco
    Karp, Judith E.
    Carboni, Joan M.
    Kaufmann, Scott H.
    CANCER RESEARCH, 2009, 69 (19) : 7635 - 7643
  • [5] Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924
    Hou, Xiaonan
    Huang, Fei
    Carboni, Joan M.
    Flatten, Karen
    Asmann, Yan W.
    Ten Eyck, Cynthia
    Nakanishi, Takeo
    Tibodeau, Jennifer D.
    Ross, Douglas D.
    Gottardis, Marco M.
    Erlichman, Charles
    Kaufmann, Scott H.
    Haluska, Paul
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (01) : 117 - 125
  • [6] Discovery of a 1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity
    Wittman, M
    Carboni, J
    Attar, R
    Balasubramanian, B
    Balimane, P
    Brassil, P
    Beaulieu, F
    Chang, CY
    Clarke, W
    Dell, J
    Eummer, J
    Frennesson, D
    Gottardis, M
    Greer, A
    Hansel, S
    Hurlburt, W
    Jacobson, B
    Krishnananthan, S
    Lee, FY
    Li, AX
    Lin, TA
    Liu, PY
    Ouellet, C
    Sang, XP
    Saulnier, MG
    Stoffan, K
    Sun, Y
    Velaparthi, U
    Wong, H
    Yang, Z
    Zimmermann, K
    Zoeckler, M
    Vyas, D
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (18) : 5639 - 5643
  • [7] Drug efflux by breast cancer resistance protein (BCRP) is a mechanism of resistance to the insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924.
    Haluska, P.
    Carboni, J. M.
    Asmann, Y. W.
    Ten, Eyck C.
    Allar, R. M.
    Tibodeau, J. D.
    Hou, X.
    Nakanishi, T.
    Ross, D. D.
    Keufmann, S. H.
    Gottardis, M. M.
    Erlichman, C.
    CANCER RESEARCH, 2009, 69 (02) : 200S - 200S
  • [8] Revisiting the Relationship Between Blood Pressure and Insulin- Like Growth Factor-1
    Schutte, Aletta Elisabeth
    Volpe, Massimo
    Tocci, Giuliano
    Conti, Elena
    HYPERTENSION, 2014, 63 (05) : 1070 - 1077
  • [9] Antitumor activity of BMS-754807, a small molecule inhibitor of insulin-like growth factor-1 receptor / insulin receptor, in combination with gemcitabine in pancreatic cancer
    Awasthi, Niranjan
    Zhang, Changhua
    Schwarz, Margaret A.
    Schwarz, Roderich E.
    CANCER RESEARCH, 2012, 72
  • [10] BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer
    Awasthi, Niranjan
    Zhang, Changhua
    Ruan, Winston
    Schwarz, Margaret A.
    Schwarz, Roderich E.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (12) : 2644 - 2653
12345